Table 1.
Baseline characteristics [mean (SD)] of participants
| PNMO (n = 120) | POMN (n = 120) | POMA (n = 120) | |
|---|---|---|---|
| Body mass index (kg m2) | 20.4 (0.5) | 26.4 (0.5)** | 26.2 (0.6)* |
| Waist circumference (cm) | 67.5 (1.4) | 80.5 (1.2)** | 82.8 (1.1) |
| Subcutaneous fat (mm) | 15.2 (0.4) | 18.5 (0.4)** | 18.2 (0.5)* |
| Body fat mass (kg) | 24.4 (1.4) | 30.4 (1.5)** | 30.6 (1.2)* |
| Total cholesterol (mg dL−1) | 172.8 (9.5) | 167.1 (8.5) | 179.7 (9.1) |
| LDL cholesterol (mg dL−1) | 114.2 (4.1) | 108.1 (6.4) | 116.4 (7.2) |
| HDL cholesterol (mg dL−1) | 35.7 (4.5) | 38.6 (4.2) | 32.7 (5.4) |
| Triglycerides (mg dL−1) | 131.5 (15.1) | 111.7 (14.6) | 139.7 (15.4) |
| Fasting blood glucose (mg dL−1) | 81.5 (5.2)* | 82.5 (7.1)** | 84.5 (6.2)* |
| C‐reactive protein (mg L−1) | 1.1 (0.04)* | 0.9 (0.05) | 1.4 (0.02) |
| Systolic blood pressure (mm Hg) | 117.2 (26.5)* | 122.5 (27.4) | 124.1 (25.1) |
| Diastolic blood pressure (mm Hg) | 74.2 (18.2) | 76.5 (19.2) | 77.1 (18.2)* |
HDL, high‐density lipoprotein; LDL, low‐density lipoprotein; PNMO, phenotypically normal metabolically obese; POMN, phenotypically obese metabolically normal; POMA, phenotypically obese metabolically abnormal. All differences are significant between groups except those marked by the following superscripts: *P > 0.05 vs. POMN group; **P > 0.05 vs. POMA group. Data are means (SD) compared between groups by analysis of variance adjusted for age and gender with post hoc Bonferroni test.